Opportunities and challenges for human papillomavirus vaccination in China
Current estimates of the HPV infection rate in China vary by geographic region (9.6–23.6%), with two age peaks in prevalence in women ≤20–25 years of age and 50–60 years of age. HPV-16, 52 and 58 are the most commonly-detected HPV genotypes in the Chinese population. In China, five HPV vaccines are...
Saved in:
| Main Authors: | Chao Zhao, Yun Zhao, Jingran Li, Mingzhu Li, Yujing Shi, Lihui Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2329450 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age
by: Tianmeng Wen, et al.
Published: (2024-12-01) -
Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohortResearch in context
by: Fanghui Zhao, et al.
Published: (2025-08-01) -
Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women
by: Susanne K. Kjaer, et al.
Published: (2024-12-01) -
Knowledge of human papillomavirus (HPV) infection and human papillomavirus vaccine among undergraduate students at a Nigerian university
by: Aisha Funmilayo Lawal, et al.
Published: (2025-05-01) -
Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
by: Ashenafi Kibret Sendekie, et al.
Published: (2025-01-01)